Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Johnson Health Tech Co's revenue for the
three
months ended in Mar. 2026 was NT$11,792 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was NT$55,511 Mil.
Johnson Health Tech Co's Revenue per Share for the
three
months ended in Mar. 2026 was NT$38.86.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was NT$182.84.
Good Sign:
Johnson Health Tech Co Ltd has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Johnson Health Tech Co was 10.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 17.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 14.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 11.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Johnson Health Tech Co's highest 3-Year average Revenue per Share Growth Rate was 17.20% per year. The lowest was -3.80% per year. And the median was 8.80% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Leisure subindustry, Johnson Health Tech Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Johnson Health Tech Co Revenue vs Travel & Leisure Industry
For the Travel & Leisure industry and Consumer Cyclical sector, Johnson Health Tech Co's Revenue distribution charts can be found below:
* The bar in red indicates where Johnson Health Tech Co's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$55,511 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Johnson Health Tech Co (TPE:1736) has a Revenue of NT$55,511 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Johnson Health Tech Co and its competitors.
Is Johnson Health Tech Co's Revenue too high?
Johnson Health Tech Co's current Revenue is NT$55,511 Mil. Overall, Johnson Health Tech Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Johnson Health Tech Co's Revenue compare to AS and HAS?
Johnson Health Tech Co's Revenue of NT$55,511 Mil can be compared against companies in the Travel & Leisure industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Travel & Leisure company?
A good Revenue depends on the Travel & Leisure industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Johnson Health Tech Co and its competitors. Johnson Health Tech Co's current Revenue is NT$55,511 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson Health Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Johnson Health Tech Co (TPE:1736) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$160.49, compared to a current price of NT$139.50 — trading 13.1% below its estimated fair value. The current Revenue is NT$55,511 Mil. Johnson Health Tech Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Johnson Health Tech Co (TPE:1736), the current Revenue is NT$55,511 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Johnson Health Tech Co (TPE:1736) Overvalued in 2026?
Based on GuruFocus' analysis, Johnson Health Tech Co stock appears to be undervalued.
The current stock price of NT$139.50 is trading 13.1% below its estimated GF Value™ of NT$160.49.
GuruFocus considers Johnson Health Tech Co to be Modestly Undervalued.
Key valuation signals for TPE:1736:
Revenue: NT$55,511 Mil
GF Value™: NT$160.49 vs. price of NT$139.50 (13.1% below fair value)
No single metric tells the full story. See the TPE:1736 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Johnson Health Tech Co Ltd is engaged in the manufacturing and selling of sports equipment, cardio equipment, weight training equipment, and related electronic components. It operates in a single industry segment with four strategic segments: American segment: In charge of selling cardiovascular equipment and research and development of training equipment in America; European segment: In charge of selling cardiovascular equipment in Europe; Asian segment: In charge of manufacturing and selling Fuji massage chairs, cardiovascular equipment and weight training equipment in Asia, and franchising the import and export of the above-mentioned products; and Others: In charge of selling cardiovascular machinery in other areas. Geographically, it operates in the Americas, Europe, Asia, and Other.
83GF Score
Get the complete analysis for TPE:1736
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1736 has been successfully added to your 
